Nordea Investment Management Ab Aerie Pharmaceuticals Inc Transaction History

Nordea Investment Management Ab

  • $85.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 19, 2022
SELL
$6.37 - $15.23 $3,904 - $9,335
-613 Reduced 0.69%
88,766 $1.34 Million
Q2 2022

Aug 09, 2022
BUY
$4.95 - $9.16 $252,796 - $467,801
51,070 Added 133.31%
89,379 $690,000
Q1 2022

Apr 11, 2022
BUY
$5.64 - $9.8 $26,795 - $46,559
4,751 Added 14.16%
38,309 $356,000
Q4 2021

Jan 20, 2022
BUY
$7.02 - $13.33 $235,577 - $447,328
33,558 New
33,558 $242,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email